Source link : https://www.newshealth.biz/health-news/new-pill-successfully-lowers-lpa-levels/
Muvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 KRAKEN trial show. Concentrations of Lp(a) cholesterol are genetically determined and remain steady throughout life. Levels of 125 nmol/L or higher promote clotting and inflammation, significantly increasing the risk for heart attack, stroke, aortic stenosis, […]
Author : News Health
Publish date : 2024-11-19 05:55:25
Copyright for syndicated content belongs to the linked Source.